MTBC Q2 2025 Earnings Presentation

Page 1

A leading provider of technology-enabled services and AI-based solutions that redefine the healthcare revenue cycle © CareCloud, Inc. 2025 Nasdaq Global Market: CCLD, CCLDO Q2 2025 RESULTS August 5, 2025

Page 2

© CareCloud, Inc. 2025 1 Safe Harbor Statements This presentation contains forward-looking statements within the meaning of the federal securities laws. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “might,” “will,” “shall,” “should,” “could,” “intends,” “expects,” “plans,” “goals,” “projects,” “anticipates,” “believes,” “seeks,” “estimates,” “forecasts,” “predicts,” “possible,” “potential,” “target,” “approximately,” or “continue” or the negative of these terms or other similar terms and phrases. Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this presentation include, without limitation, statements reflecting management’s expectations for future financial performance and operating expenditures, expected growth, including our ability to continue as a going concern, to raise additional capital and to succeed in our future operations, profitability and business outlook, increased sales and marketing expenses, and the expected results from the integration of our acquisitions. Forward-looking statements are only current predictions and are subject to substantial known and unknown risks, uncertainties, and other factors that may cause our (or our industry’s) actual results, levels of activity, performance, or achievements to be materially different from those anticipated by such statements. These factors include our ability to: • Manage our growth, including acquiring, partnering with, and effectively integrating acquired businesses into our infrastructure and avoiding legal exposure and liabilities associated with acquired companies and assets; • Retain our clients and revenue levels, including effectively migrating new clients and maintaining or growing the revenue levels of our new and existing clients; • Maintain operations in Pakistan, Azad Jammu and Kashmir, and Sri Lanka (together, the “Offshore Offices”) in a manner that continues to enable us to offer competitively priced products and services; • Keep pace with a rapidly changing healthcare industry; • Consistently achieve and maintain compliance with a myriad of federal, state, foreign, local, payor and industry requirements, regulations, rules, laws and contracts; • Maintain and protect the privacy of confidential and protected Company, client and patient information; • Develop new technologies, upgrade and adapt legacy and acquired technologies to work with evolving industry standards and third-party software platforms and technologies, and protect and enforce all of these and other intellectual property rights; • Attract and retain key officers and employees, and the continued involvement of Mahmud Haq as Executive Chairman and A. Hadi Chaudhry as Chief Executive Officer, all of which are critical to our ongoing operations and growing our business; • Realize the expected cost savings and benefits from our restructuring activities and structural cost reductions; • Comply with covenants contained in our credit agreement with our senior secured lender, Silicon Valley Bank, a division of First Citizens Bank, and other future debt facilities; • Resume and then continue to pay our monthly dividends to the holders of our Series A and Series B preferred stock; • Incorporate AI into our products faster and more successfully than our competitors, protecting the privacy of medical records and cybersecurity threats; • Compete with other companies developing products and selling services competitive with ours, and who may have greater resources and name recognition than we have; • Effectively integrate, manage and keep our information systems secure and operational in the event of a cyber-attack; • Respond to the uncertainty resulting from pandemics, epidemics or other public health emergencies and the impact they may have on our operations, the demand for our services, our projected results of operations, financial performance or other financial metrics or any of the foregoing risks and economic activity in general; • Keep and increase market acceptance of our products and services; • Adapt to changes in domestic and foreign business, market, financial, political and legal conditions Although we believe that the expectations reflected in the forward-looking statements contained in this presentation are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. In this presentation, we disclose certain non-GAAP historical and projected financial measures, including adjusted EBITDA. We believe that these non-GAAP financial measures provide useful information to both management and investors by excluding certain items and expenses that are not indicative of our core operating results or do not reflect our normal business operations. Our use of non-GAAP financial measures has certain limitations in that such non-GAAP financial measures may not be directly comparable to those reported by other companies. We seek to compensate for the limitation of our non-GAAP presentation by providing a detailed reconciliation of the non-GAAP financial measures to the most directly comparable U.S. GAAP measures. Investors are encouraged to review the related U.S. GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable U.S. GAAP financial measures. The statements in this presentation are made as of the date of this presentation, and the Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.

Page 3

2 Hosts for Second Quarter 2025 Earnings Call 2 © CareCloud, Inc. 2025 Mahmud Haq Founder & Executive Chairman Norman Roth Interim CFO and Corporate Controller Stephen Snyder Co-Chief Executive Officer A. Hadi Chaudhry Co-Chief Executive Officer

Page 4

Page 5

Page 6

Page 7

Page 8

Page 9

© CareCloud, Inc. 2025 8 2025 Guidance Revenue Adjusted EBITDA Earnings per Share $110.8 $111 - $114 ( 1 0 .0 0 ) 1 0 .0 0 3 0 .0 0 5 0 .0 0 7 0 .0 0 9 0 .0 0 1 1 0 . 0 0 1 3 0 . 0 0 FY 2024 FY 2025 $ in millions Actual Guidance Range $24.1 $26 - $28 ( 1 . 0 0 ) 4 .0 0 9 .0 0 1 4 .0 0 1 9 .0 0 2 4 .0 0 2 9 .0 0 FY 2024 FY 2025 $ in millions Actual Guidance Range ($0.28) $0.10 - $0.13 (0 .35) (0 .30) (0 .25) (0 .20) (0 .15) (0 .10) (0 .05) - 0.05 0.10 0.15 0.20 FY 2024 FY 2025 Actual Guidance Range

Page 10

Page 11

Page 12

© CareCloud, Inc. 2025 11 AI Applications cirrusAI Notes cirrusAI Voice AI Call Audit & Monitoring • Agent scoring • Call sentiment analysis • 100% call audit • Highlighting areas of call improvement • Internally deployed at call center AI Documentation Assistant • Ambient Listening • Smart Summarization • Specialty Specific Logic Application • Streamline Documentation • User Base Doubled

Page 13

Page 14

© CareCloud, Inc. 2025 13 Critical Access Hospital ONC Certified Access to inpatient EHR market – a $1.5 billion market Rural setting at forefront of design More than half of rural and CAH hospitals looking for a change Certified Medicare compliance AI-enabled for inpatient, outpatient and swing bed workflows

Page 15

Page 16

© CareCloud, Inc. 2025 15 Q2 2025 Highlights $ in millions. See reconciliations of non-GAAP results in the Appendix $28.1 $27.4 - 5. 00 10. 00 15. 00 20. 00 25. 00 30. 00 Q2 2024 Q2 2025 Revenue $1.7 $2.9 0% 2% 4% 6% 8% 10% 12% - 0. 50 1. 00 1. 50 2. 00 2. 50 3. 00 3. 50 Q2 2024 Q2 2025 Net income $6.4 $6.5 22% 22% 22% 23% 23% 23% 23% 23% 24% 24% 24% - 1. 00 2. 00 3. 00 4. 00 5. 00 6. 00 7. 00 Q2 2024 Q2 2025 Adjusted EBITDA ($0.14) $0.04 22% 22% 22% 23% 23% 23% 23% 23% 24% 24% 24% - 0. 16 - 0. 14 - 0. 12 - 0. 1 - 0. 08 - 0. 06 - 0. 04 - 0. 02 0 0. 02 0. 04 0. 06 Q2 2024 Q2 2025 Earnings Per Share $2.7 $5.4 22% 22% 22% 23% 23% 23% 23% 23% 24% 24% 24% 0 1 2 3 4 5 6 Q2 2024 Q2 2025 Free Cash Flow

Page 17

© CareCloud, Inc. 2025 16 YTD 2025 Highlights $ in millions. See reconciliations of non-GAAP results in the Appendix $54.1 $55.0 - 10.0 0 20.0 0 30.0 0 40.0 0 50.0 0 60.0 0 YTD 2024 YTD 2025 Revenue $1.4 $4.9 0% 1% 2% 3% 4% 5% 6% 7% 8% 9% 10% - 1.00 2.00 3.00 4.00 5.00 6.00 YTD 2024 YTD 2025 Net income ($0.24) $0.02 16% 17% 18% 19% 20% 21% 22% 23% - 0. 25 - 0. 2 - 0. 15 - 0. 1 - 0. 05 0 0. 05 YTD 2024 YTD 2025 Earnings Per Share $10.1 $12.1 16% 17% 18% 19% 20% 21% 22% 23% - 2.00 4.00 6.00 8.00 10.0 0 12.0 0 14.0 0 YTD 2024 YTD 2025 Adjusted EBITDA $4.9 $9.0 16% 17% 18% 19% 20% 21% 22% 23% 0 1 2 3 4 5 6 7 8 9 10 YTD 2024 YTD 2025 Free Cash Flow

Page 18

Nasdaq Global Market: CCLD, CCLDP, CCLDO © CareCloud, Inc. 2025 Thank You! 17 Stephen Snyder ir@carecloud.com Corporate carecloud.com Investor Relations ir.carecloud.com

Page 19

Page 20

© CareCloud, Inc. 2025 19 Non-GAAP Financial Measures Reconciliation ($000s) Adjusted EBITDA to GAAP net (loss) income FY 2023 FY 2024 Q2 2024 Q2 2025 YTD 2024 YTD 2025 GAAP net (loss) income (48,674)$ 7,851$ 1,674$ 2,902$ 1,433$ 4,850$ (Benefit) provision for income taxes (364) 160 39 42 78 83 Net interest expense 1,040 812 264 17 602 33 Foreign exchange / other expense 918 335 306 41 301 60 Stock-based compensation expense (benefit) 4,716 115 265 111 (443) 219 Depreciation and amortization 14,402 14,142 3,714 3,382 7,644 6,719 Transaction and integration costs 286 46 11 11 23 23 Goodwill impairment charges 42,000 - - - - - Lease termination, unoccupied lease charges and restructuring cost 1,105 596 116 23 438 137 Adjusted EBITDA 15,429$ 24,057$ 6,389$ 6,529$ 10,076$ 12,124$ ($000s) Adjusted net income to GAAP net (loss) income FY 2023 FY 2024 Q2 2024 Q2 2025 YTD 2024 YTD 2025 GAAP net (loss) income (48,674)$ 7,851$ 1,674$ 2,902$ 1,433$ 4,850$ Foreign exchange / other expense 918 335 306 41 301 60 Stock-based compensation expense (benefit) 4,716 115 265 111 (443) 219 Amortization of purchased intangible assets 4,975 1,577 586 193 1,426 282 Transaction and integration costs 286 46 11 11 23 23 Goodwill impairment charges 42,000 - - - - - Lease termination, unoccupied lease charges and restructuring cost 1,105 596 116 23 438 137 Income tax (benefit) related to goodwill (525) - - - - - Non-GAAP adjusted Net Income 4,801$ 10,520$ 2,958$ 3,281$ 3,178$ 5,571$ ($000s) Net cash provided by operating activities to free cash flow FY 2023 FY 2024 Q2 2024 Q2 2025 YTD 2024 YTD 2025 Net cash provided by operating activities 15,461$ 20,642$ 4,279$ 7,408$ 8,345$ 12,521$ Purchases of property and equipment (3,063) (1,697) (127) (1,162) (425) (1,786) Capitalized software and other intangible assets (8,550) (5,709) (1,476) (831) (3,046) (1,677) Initial payment for acquisition - - - - - (40) Free cash flow 3,848$ 13,236$ 2,676$ 5,415$ 4,874$ 9,018$ Net cash used in investing activities (11,613)$ (7,406)$ (1,603)$ (1,993)$ (3,471)$ (3,503)$ Net cash used in financing activities (13,285)$ (11,256)$ (4,138)$ (1,762)$ (5,512)$ (3,694)$

Slides